此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

评估将免疫治疗药物 Atezolizumab 添加到标准化疗治疗晚期或转移性肺外起源的神经内分泌癌

2026年11月5日 更新者:National Cancer Institute (NCI)

Randomized Phase II/III Trial of First Line Platinum/Etoposide With or Without Atezolizumab (NSC#783608) in Patients With Advanced or Metastatic Poorly Differentiated Extrapulmonary Neuroendocrine Carcinomas (NEC)

This phase II/III trial compares the effect of immunotherapy with atezolizumab in combination with standard chemotherapy with a platinum drug (cisplatin or carboplatin) and etoposide versus standard therapy alone for the treatment of poorly differentiated extrapulmonary (originated outside the lung) neuroendocrine cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that has spread from where it first started (primary site) to other places in the body (metastatic). The other aim of this trial is to compare using atezolizumab just at the beginning of treatment versus continuing it beyond the initial treatment. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cisplatin and carboplatin are in a class of medications known as platinum-containing compounds that work by killing, stopping or slowing the growth of cancer cells. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair, and it may kill cancer cells. Giving atezolizumab in combination with a platinum drug (cisplatin or carboplatin) and etoposide may work better in treating patients with poorly differentiated extrapulmonary neuroendocrine cancer compared to standard therapy with a platinum drug (cisplatin or carboplatin) and etoposide alone.

研究概览

详细说明

PRIMARY OBJECTIVES:

I. Compare the combination of induction platinum/etoposide and atezolizumab followed by maintenance atezolizumab (Arm 1) versus induction platinum/etoposide alone (Arm 3).

II. Compare the combination of induction platinum/etoposide and atezolizumab followed by observation (Arm 2) versus induction platinum/etoposide alone (Arm 3).

III. Compare the combination of induction platinum/etoposide and atezolizumab followed by maintenance atezolizumab (Arm 1) versus the combination of induction platinum/etoposide and atezolizumab followed by observation (Arm 2).

SECONDARY OBJECTIVES:

I. To compare overall survival (OS), measured from start of observation/maintenance, across arms.

II. To compare progression free survival (PFS) (measured from randomization and measured from start of observation/maintenance) across arms.

III. To compare objective response rate (ORR = confirmed and unconfirmed partial response [PR] + confirmed and unconfirmed complete response [CR]) across arms among patients with measurable disease at randomization.

IV. To compare clinical benefit rate (CBR = confirmed and unconfirmed PR + confirmed and unconfirmed CR + stable disease [SD]) across arms among patients with measurable disease at randomization.

V. To compare duration of response (DOR) across arms. VI. To evaluate the safety and tolerability of each arm.

ADDITIONAL OBJECTIVE:

I. To bank tumor and blood samples for future biomarker correlative studies.

OUTLINE: Patients are randomized to 1 of 3 arms.

ARM I: During induction phase, patients receive atezolizumab intravenously (IV) over 30-60 minutes on day 1 of each cycle, carboplatin IV over 30 minutes or cisplatin IV over 60 minutes on day 1 of each cycle, and etoposide IV on days 1-3 of each cycle. Treatment repeats every 21 days for 4 cycles in the absence of disease progression or unacceptable toxicity. During maintenance phase, patients receive atezolizumab IV over 30-60 minutes on day 1 of each cycle. Treatment repeats every 21 days for up to 17 cycles in the absence of disease progression or unacceptable toxicity.

ARM II (CLOSED TO ACCRUAL 7/9/26): During induction phase, patients receive atezolizumab IV over 30-60 minutes on day 1 of each cycle, carboplatin IV over 30 minutes or cisplatin IV over 60 minutes on day 1 of each cycle, and etoposide IV on days 1-3 of each cycle. Treatment repeats every 21 days for 4 cycles in the absence of disease progression or unacceptable toxicity. Patients then undergo observation for 1 year.

ARM III: During induction phase, patients receive carboplatin IV over 30 minutes or cisplatin IV over 60 minutes on day 1 of each cycle and etoposide IV on days 1-3 of each cycle. Treatment repeats every 21 days for 4 cycles in the absence of disease progression or unacceptable toxicity. Patients then undergo observation for 1 year.

Patients in all arms also undergo computed tomography (CT) scan and/or magnetic resonance imaging (MRI) throughout the trial and blood sample collection on study.

After completion of study treatment, patients are followed up for 5 years.

研究类型

介入性

注册 (估计的)

189

阶段

  • 阶段2
  • 第三阶段

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Alaska
      • Anchorage、Alaska、美国、99508
        • 暂停
        • Alaska Women's Cancer Care
    • Arizona
      • Phoenix、Arizona、美国、85004
      • Phoenix、Arizona、美国、85054
        • 招聘中
        • Mayo Clinic Hospital in Arizona
        • 首席研究员:
          • Jacob Orme
        • 接触:
          • Site Public Contact
          • 电话号码:855-776-0015
    • California
      • Anaheim、California、美国、92806
        • 招聘中
        • Kaiser Permanente-Anaheim
        • 接触:
        • 首席研究员:
          • Helen H. Moon
      • Auburn、California、美国、95602
      • Auburn、California、美国、95603
        • 招聘中
        • Sutter Cancer Centers Radiation Oncology Services-Auburn
        • 首席研究员:
          • Kristie A. Bobolis
        • 接触:
      • Baldwin Park、California、美国、91706
        • 招聘中
        • Kaiser Permanente-Baldwin Park
        • 接触:
        • 首席研究员:
          • Helen H. Moon
      • Bellflower、California、美国、90706
        • 招聘中
        • Kaiser Permanente-Bellflower
        • 接触:
        • 首席研究员:
          • Helen H. Moon
      • Berkeley、California、美国、94704
        • 招聘中
        • Alta Bates Summit Medical Center-Herrick Campus
        • 首席研究员:
          • Kristie A. Bobolis
        • 接触:
      • Cameron Park、California、美国、95682
        • 招聘中
        • Sutter Cancer Centers Radiation Oncology Services-Cameron Park
        • 首席研究员:
          • Kristie A. Bobolis
        • 接触:
      • Carmichael、California、美国、95608
      • Carmichael、California、美国、95608
      • Elk Grove、California、美国、95758
      • Fontana、California、美国、92335
        • 招聘中
        • Kaiser Permanente-Fontana
        • 接触:
        • 首席研究员:
          • Helen H. Moon
      • Fremont、California、美国、94538
      • Harbor City、California、美国、90710
        • 招聘中
        • Kaiser Permanente South Bay
        • 接触:
        • 首席研究员:
          • Helen H. Moon
      • Irvine、California、美国、92618
        • 招聘中
        • Kaiser Permanente-Irvine
        • 接触:
        • 首席研究员:
          • Helen H. Moon
      • Los Angeles、California、美国、90027
        • 招聘中
        • Kaiser Permanente Los Angeles Medical Center
        • 接触:
        • 首席研究员:
          • Helen H. Moon
      • Los Angeles、California、美国、90034
        • 招聘中
        • Kaiser Permanente West Los Angeles
        • 接触:
        • 首席研究员:
          • Helen H. Moon
      • Modesto、California、美国、95355
      • Mountain View、California、美国、94040
        • 招聘中
        • Palo Alto Medical Foundation-Camino Division
        • 首席研究员:
          • Kristie A. Bobolis
        • 接触:
      • Ontario、California、美国、91761
        • 招聘中
        • Kaiser Permanente-Ontario
        • 接触:
        • 首席研究员:
          • Helen H. Moon
      • Palo Alto、California、美国、94301
      • Panorama City、California、美国、91402
        • 招聘中
        • Kaiser Permanente - Panorama City
        • 接触:
        • 首席研究员:
          • Helen H. Moon
      • Riverside、California、美国、92505
        • 招聘中
        • Kaiser Permanente-Riverside
        • 接触:
        • 首席研究员:
          • Helen H. Moon
      • Rocklin、California、美国、95765
      • Roseville、California、美国、95661
        • 招聘中
        • Sutter Cancer Centers Radiation Oncology Services-Roseville
        • 首席研究员:
          • Kristie A. Bobolis
        • 接触:
      • Roseville、California、美国、95661
      • Sacramento、California、美国、95816
      • Sacramento、California、美国、95816
      • San Diego、California、美国、92120
        • 招聘中
        • Kaiser Permanente-San Diego Zion
        • 接触:
        • 首席研究员:
          • Helen H. Moon
      • San Francisco、California、美国、94115
        • 招聘中
        • California Pacific Medical Center-Pacific Campus
        • 首席研究员:
          • Kristie A. Bobolis
        • 接触:
      • San Marcos、California、美国、92078
        • 招聘中
        • Kaiser Permanente-San Marcos
        • 接触:
        • 首席研究员:
          • Helen H. Moon
      • Santa Cruz、California、美国、95065
      • Santa Rosa、California、美国、95403
        • 招聘中
        • Sutter Pacific Medical Foundation
        • 首席研究员:
          • Kristie A. Bobolis
        • 接触:
      • Sunnyvale、California、美国、94086
      • Vallejo、California、美国、94589
        • 招聘中
        • Sutter Solano Medical Center/Cancer Center
        • 首席研究员:
          • Kristie A. Bobolis
        • 接触:
      • Woodland、California、美国、95695
      • Woodland Hills、California、美国、91367
        • 招聘中
        • Kaiser Permanente-Woodland Hills
        • 接触:
        • 首席研究员:
          • Helen H. Moon
    • Colorado
      • Denver、Colorado、美国、80210
      • Littleton、Colorado、美国、80122
      • Parker、Colorado、美国、80138
    • Connecticut
      • Derby、Connecticut、美国、06418
        • 招聘中
        • Smilow Cancer Hospital-Derby Care Center
        • 接触:
        • 首席研究员:
          • Matthew Austin
      • Fairfield、Connecticut、美国、06824
        • 招聘中
        • Smilow Cancer Hospital Care Center-Fairfield
        • 接触:
        • 首席研究员:
          • Matthew Austin
      • Glastonbury、Connecticut、美国、06033
        • 暂停
        • Smilow Cancer Hospital Care Center at Glastonbury
      • Greenwich、Connecticut、美国、06830
        • 招聘中
        • Smilow Cancer Hospital Care Center at Greenwich
        • 接触:
        • 首席研究员:
          • Matthew Austin
      • Guilford、Connecticut、美国、06437
        • 招聘中
        • Smilow Cancer Hospital Care Center - Guilford
        • 接触:
        • 首席研究员:
          • Matthew Austin
      • Hartford、Connecticut、美国、06105
        • 暂停
        • Smilow Cancer Hospital Care Center at Saint Francis
      • New Haven、Connecticut、美国、06520
        • 招聘中
        • Yale University
        • 接触:
        • 首席研究员:
          • Matthew Austin
      • North Haven、Connecticut、美国、06473
        • 招聘中
        • Yale-New Haven Hospital North Haven Medical Center
        • 接触:
        • 首席研究员:
          • Matthew Austin
      • Stamford、Connecticut、美国、06902
        • 招聘中
        • Smilow Cancer Hospital Care Center at Long Ridge
        • 接触:
        • 首席研究员:
          • Matthew Austin
      • Torrington、Connecticut、美国、06790
        • 招聘中
        • Smilow Cancer Hospital-Torrington Care Center
        • 接触:
        • 首席研究员:
          • Matthew Austin
      • Trumbull、Connecticut、美国、06611
        • 招聘中
        • Smilow Cancer Hospital Care Center-Trumbull
        • 接触:
        • 首席研究员:
          • Matthew Austin
      • Waterbury、Connecticut、美国、06708
        • 招聘中
        • Smilow Cancer Hospital-Waterbury Care Center
        • 接触:
        • 首席研究员:
          • Matthew Austin
      • Waterford、Connecticut、美国、06385
        • 招聘中
        • Smilow Cancer Hospital Care Center - Waterford
        • 接触:
        • 首席研究员:
          • Matthew Austin
    • Florida
      • Fort Lauderdale、Florida、美国、33308
      • Jacksonville、Florida、美国、32224-9980
        • 招聘中
        • Mayo Clinic in Florida
        • 首席研究员:
          • Jacob Orme
        • 接触:
          • Site Public Contact
          • 电话号码:855-776-0015
      • Tampa、Florida、美国、33612
        • 招聘中
        • Moffitt Cancer Center
        • 接触:
        • 首席研究员:
          • Mintallah Haider
    • Hawaii
      • Honolulu、Hawaii、美国、96813
        • 招聘中
        • Hawaii Cancer Care Inc - Waterfront Plaza
        • 接触:
        • 首席研究员:
          • Elizabeth S. Nakasone
      • Honolulu、Hawaii、美国、96813
        • 招聘中
        • Queen's Cancer Cenrer - POB I
        • 接触:
          • Site Public Contact
          • 电话号码:808-532-0315
        • 首席研究员:
          • Elizabeth S. Nakasone
      • Honolulu、Hawaii、美国、96813
        • 招聘中
        • Queen's Medical Center
        • 接触:
          • Site Public Contact
          • 电话号码:808-545-8548
        • 首席研究员:
          • Elizabeth S. Nakasone
      • Honolulu、Hawaii、美国、96813
        • 招聘中
        • Straub Clinic and Hospital
        • 接触:
          • Site Public Contact
          • 电话号码:808-522-4333
        • 首席研究员:
          • Elizabeth S. Nakasone
      • Honolulu、Hawaii、美国、96813
        • 招聘中
        • University of Hawaii Cancer Center
        • 接触:
          • Site Public Contact
          • 电话号码:808-586-2979
        • 首席研究员:
          • Elizabeth S. Nakasone
      • Honolulu、Hawaii、美国、96817
        • 招聘中
        • Queen's Cancer Center - Kuakini
        • 接触:
          • Site Public Contact
          • 电话号码:808-531-8521
        • 首席研究员:
          • Elizabeth S. Nakasone
      • ‘Aiea、Hawaii、美国、96701
        • 招聘中
        • Hawaii Cancer Care - Westridge
        • 接触:
        • 首席研究员:
          • Elizabeth S. Nakasone
      • ‘Aiea、Hawaii、美国、96701
        • 暂停
        • Pali Momi Medical Center
      • ‘Ewa Beach、Hawaii、美国、96706
        • 招聘中
        • The Queen's Medical Center - West Oahu
        • 接触:
        • 首席研究员:
          • Elizabeth S. Nakasone
    • Idaho
      • Coeur d'Alene、Idaho、美国、83814
        • 招聘中
        • Kootenai Health - Coeur d'Alene
        • 首席研究员:
          • John M. Schallenkamp
        • 接触:
      • Nampa、Idaho、美国、83687
        • 招聘中
        • Saint Alphonsus Cancer Care Center-Nampa
        • 接触:
        • 首席研究员:
          • Tareq Al baghdadi
      • Post Falls、Idaho、美国、83854
        • 招聘中
        • Kootenai Clinic Cancer Services - Post Falls
        • 首席研究员:
          • John M. Schallenkamp
        • 接触:
      • Sandpoint、Idaho、美国、83864
        • 招聘中
        • Kootenai Clinic Cancer Services - Sandpoint
        • 首席研究员:
          • John M. Schallenkamp
        • 接触:
    • Illinois
      • Aurora、Illinois、美国、60504
        • 暂停
        • Rush-Copley Medical Center
      • Centralia、Illinois、美国、62801
        • 招聘中
        • Centralia Oncology Clinic
        • 首席研究员:
          • Bryan A. Faller
        • 接触:
      • Chicago、Illinois、美国、60637
        • 招聘中
        • University of Chicago Comprehensive Cancer Center
        • 接触:
        • 首席研究员:
          • Ardaman Shergill
      • Chicago、Illinois、美国、60611
        • 招聘中
        • Northwestern University
        • 首席研究员:
          • Mary F. Mulcahy
        • 接触:
      • Danville、Illinois、美国、61832
        • 招聘中
        • Carle at The Riverfront
        • 首席研究员:
          • Vamsi K. Vasireddy
        • 接触:
      • DeKalb、Illinois、美国、60115
        • 招聘中
        • Northwestern Medicine Cancer Center Kishwaukee
        • 首席研究员:
          • Mary F. Mulcahy
        • 接触:
      • Decatur、Illinois、美国、62526
        • 招聘中
        • Cancer Care Specialists of Illinois - Decatur
        • 首席研究员:
          • Bryan A. Faller
        • 接触:
      • Decatur、Illinois、美国、62526
        • 招聘中
        • Decatur Memorial Hospital
        • 首席研究员:
          • Bryan A. Faller
        • 接触:
      • Effingham、Illinois、美国、62401
        • 招聘中
        • Carle Physician Group-Effingham
        • 接触:
        • 首席研究员:
          • Vamsi K. Vasireddy
      • Effingham、Illinois、美国、62401
        • 招聘中
        • Crossroads Cancer Center
        • 首席研究员:
          • Bryan A. Faller
        • 接触:
      • Geneva、Illinois、美国、60134
        • 招聘中
        • Northwestern Medicine Cancer Center Delnor
        • 首席研究员:
          • Mary F. Mulcahy
        • 接触:
      • Glenview、Illinois、美国、60026
        • 招聘中
        • Northwestern Medicine Glenview Outpatient Center
        • 首席研究员:
          • Mary F. Mulcahy
        • 接触:
          • Site Public Contact
          • 电话号码:312-695-1102
      • Grayslake、Illinois、美国、60030
        • 招聘中
        • Northwestern Medicine Grayslake Outpatient Center
        • 首席研究员:
          • Mary F. Mulcahy
        • 接触:
          • Site Public Contact
          • 电话号码:312-695-1102
      • Harvey、Illinois、美国、60426
        • 招聘中
        • Ingalls Memorial Hospital
        • 首席研究员:
          • James A. Wallace
        • 接触:
      • Lake Forest、Illinois、美国、60045
        • 招聘中
        • Northwestern Medicine Lake Forest Hospital
        • 首席研究员:
          • Mary F. Mulcahy
        • 接触:
      • Mattoon、Illinois、美国、61938
        • 招聘中
        • Carle Physician Group-Mattoon/Charleston
        • 接触:
        • 首席研究员:
          • Vamsi K. Vasireddy
      • Mount Vernon、Illinois、美国、62864
        • 招聘中
        • SSM Health Good Samaritan
        • 首席研究员:
          • Jay W. Carlson
        • 接触:
      • New Lenox、Illinois、美国、60451
        • 招聘中
        • UC Comprehensive Cancer Center at Silver Cross
        • 接触:
        • 首席研究员:
          • Ardaman Shergill
      • Normal、Illinois、美国、61761
        • 招聘中
        • Carle BroMenn Medical Center
        • 首席研究员:
          • Vamsi K. Vasireddy
        • 接触:
      • Normal、Illinois、美国、61761
        • 招聘中
        • Carle Cancer Institute Normal
        • 首席研究员:
          • Vamsi K. Vasireddy
        • 接触:
      • O'Fallon、Illinois、美国、62269
        • 招聘中
        • Cancer Care Center of O'Fallon
        • 首席研究员:
          • Bryan A. Faller
        • 接触:
      • Orland Park、Illinois、美国、60462
        • 招聘中
        • University of Chicago Medicine-Orland Park
        • 接触:
        • 首席研究员:
          • Ardaman Shergill
      • Orland Park、Illinois、美国、60462
      • Rockford、Illinois、美国、61114
        • 招聘中
        • UW Health Carbone Cancer Center Rockford
        • 接触:
        • 首席研究员:
          • Fahrettin Covut
      • Springfield、Illinois、美国、62702
        • 招聘中
        • Southern Illinois University School of Medicine
        • 首席研究员:
          • Bryan A. Faller
        • 接触:
          • Site Public Contact
          • 电话号码:217-545-7929
      • Springfield、Illinois、美国、62702
        • 招聘中
        • Springfield Clinic
        • 首席研究员:
          • Bryan A. Faller
        • 接触:
          • Site Public Contact
          • 电话号码:800-444-7541
      • Springfield、Illinois、美国、62781
        • 招聘中
        • Springfield Memorial Hospital
        • 首席研究员:
          • Bryan A. Faller
        • 接触:
      • Urbana、Illinois、美国、61801
        • 招聘中
        • Carle Cancer Center
        • 接触:
        • 首席研究员:
          • Vamsi K. Vasireddy
      • Warrenville、Illinois、美国、60555
        • 招聘中
        • Northwestern Medicine Cancer Center Warrenville
        • 首席研究员:
          • Mary F. Mulcahy
        • 接触:
      • Yorkville、Illinois、美国、60560
        • 暂停
        • Rush-Copley Healthcare Center
    • Indiana
      • Crown Point、Indiana、美国、46307
        • 招聘中
        • UChicago Medicine Northwest Indiana
        • 首席研究员:
          • Ardaman Shergill
        • 接触:
    • Iowa
      • Ames、Iowa、美国、50010
        • 招聘中
        • Mary Greeley Medical Center
        • 首席研究员:
          • Joseph J. Merchant
        • 接触:
          • Site Public Contact
          • 电话号码:515-956-4132
      • Ames、Iowa、美国、50010
        • 招聘中
        • McFarland Clinic - Ames
        • 首席研究员:
          • Joseph J. Merchant
        • 接触:
      • Ankeny、Iowa、美国、50023
        • 招聘中
        • UI Health Care Mission Cancer and Blood - Ankeny Clinic
        • 接触:
          • Site Public Contact
          • 电话号码:515-241-3305
        • 首席研究员:
          • Seema Harichand-Herdt
      • Boone、Iowa、美国、50036
        • 暂停
        • McFarland Clinic - Boone
      • Carroll、Iowa、美国、51401
        • 招聘中
        • Saint Anthony Regional Hospital
        • 接触:
        • 首席研究员:
          • Seema Harichand-Herdt
      • Clive、Iowa、美国、50325
        • 招聘中
        • Mercy Cancer Center-West Lakes
        • 接触:
          • Site Public Contact
          • 电话号码:515-241-3305
        • 首席研究员:
          • Richard L. Deming
      • Clive、Iowa、美国、50325
        • 招聘中
        • UI Health Care Mission Cancer and Blood - West Des Moines Clinic
        • 接触:
          • Site Public Contact
          • 电话号码:515-241-3305
        • 首席研究员:
          • Seema Harichand-Herdt
      • Creston、Iowa、美国、50801
        • 主动,不招人
        • Greater Regional Medical Center
      • Des Moines、Iowa、美国、50314
        • 招聘中
        • Broadlawns Medical Center
        • 接触:
          • Site Public Contact
          • 电话号码:515-282-2200
        • 首席研究员:
          • Seema Harichand-Herdt
      • Des Moines、Iowa、美国、50314
        • 招聘中
        • Mercy Medical Center - Des Moines
        • 接触:
          • Site Public Contact
          • 电话号码:515-241-3305
        • 首席研究员:
          • Richard L. Deming
      • Des Moines、Iowa、美国、50309
        • 招聘中
        • Iowa Methodist Medical Center
        • 接触:
          • Site Public Contact
          • 电话号码:515-241-6727
        • 首席研究员:
          • Seema Harichand-Herdt
      • Des Moines、Iowa、美国、50309
        • 招聘中
        • UI Health Care Mission Cancer and Blood - Des Moines Clinic
        • 接触:
          • Site Public Contact
          • 电话号码:515-241-3305
        • 首席研究员:
          • Seema Harichand-Herdt
      • Des Moines、Iowa、美国、50314
        • 招聘中
        • UI Health Care Mission Cancer and Blood - Laurel Clinic
        • 接触:
          • Site Public Contact
          • 电话号码:515-241-3305
        • 首席研究员:
          • Seema Harichand-Herdt
      • Fort Dodge、Iowa、美国、50501
        • 招聘中
        • McFarland Clinic - Trinity Cancer Center
        • 首席研究员:
          • Joseph J. Merchant
        • 接触:
          • Site Public Contact
          • 电话号码:515-956-4132
      • Jefferson、Iowa、美国、50129
        • 暂停
        • McFarland Clinic - Jefferson
      • Marshalltown、Iowa、美国、50158
        • 招聘中
        • McFarland Clinic - Marshalltown
        • 首席研究员:
          • Joseph J. Merchant
        • 接触:
          • Site Public Contact
          • 电话号码:515-956-4132
      • Waukee、Iowa、美国、50263
        • 招聘中
        • UI Health Care Mission Cancer and Blood - Waukee Clinic
        • 接触:
          • Site Public Contact
          • 电话号码:515-241-3305
        • 首席研究员:
          • Seema Harichand-Herdt
      • West Des Moines、Iowa、美国、50266
        • 招聘中
        • Mercy Medical Center-West Lakes
        • 接触:
          • Site Public Contact
          • 电话号码:515-241-3305
        • 首席研究员:
          • Richard L. Deming
    • Louisiana
      • Baton Rouge、Louisiana、美国、70805
        • 招聘中
        • LSU Health Baton Rouge-North Clinic
        • 接触:
        • 首席研究员:
          • Marshall P. Stagg
      • Baton Rouge、Louisiana、美国、70808
        • 招聘中
        • Our Lady of the Lake Physician Group
        • 接触:
        • 首席研究员:
          • Marshall P. Stagg
      • Metairie、Louisiana、美国、70006
        • 招聘中
        • East Jefferson General Hospital
        • 接触:
        • 首席研究员:
          • Tara Castellano
      • Metairie、Louisiana、美国、70006
        • 招聘中
        • LSU Healthcare Network / Metairie Multi-Specialty Clinic
        • 接触:
        • 首席研究员:
          • Tara Castellano
      • New Orleans、Louisiana、美国、70112
        • 招聘中
        • University Medical Center New Orleans
        • 接触:
        • 首席研究员:
          • Tara Castellano
    • Massachusetts
      • Burlington、Massachusetts、美国、01805
      • Peabody、Massachusetts、美国、01960
    • Michigan
      • Ann Arbor、Michigan、美国、48109
        • 招聘中
        • University of Michigan Rogel Cancer Center
        • 首席研究员:
          • Vaibhav Sahai
        • 接触:
      • Ann Arbor、Michigan、美国、48106
        • 招聘中
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
        • 接触:
        • 首席研究员:
          • Tareq Al baghdadi
      • Battle Creek、Michigan、美国、49017
        • 招聘中
        • Bronson Battle Creek
        • 接触:
        • 首席研究员:
          • Kathleen Y. Butler
      • Brighton、Michigan、美国、48114
        • 招聘中
        • Trinity Health IHA Medical Group Hematology Oncology - Brighton
        • 接触:
        • 首席研究员:
          • Tareq Al baghdadi
      • Brighton、Michigan、美国、48114
        • 招聘中
        • Trinity Health Medical Center - Brighton
        • 接触:
        • 首席研究员:
          • Tareq Al baghdadi
      • Brownstown、Michigan、美国、48183
        • 招聘中
        • Henry Ford Cancer Institute-Downriver
        • 接触:
        • 首席研究员:
          • Haythem Y. Ali
      • Canton、Michigan、美国、48188
        • 招聘中
        • Trinity Health IHA Medical Group Hematology Oncology - Canton
        • 接触:
        • 首席研究员:
          • Tareq Al baghdadi
      • Canton、Michigan、美国、48188
      • Chelsea、Michigan、美国、48118
        • 招聘中
        • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
        • 接触:
        • 首席研究员:
          • Tareq Al baghdadi
      • Chelsea、Michigan、美国、48118
      • Clinton Township、Michigan、美国、48038
        • 招聘中
        • Henry Ford Macomb Hospital-Clinton Township
        • 接触:
        • 首席研究员:
          • Haythem Y. Ali
      • Dearborn、Michigan、美国、48126
        • 招聘中
        • Henry Ford Medical Center-Fairlane
        • 接触:
        • 首席研究员:
          • Haythem Y. Ali
      • Dearborn、Michigan、美国、48124
        • 招聘中
        • Corewell Health Dearborn Hospital
        • 接触:
          • Site Public Contact
          • 电话号码:248-551-7695
        • 首席研究员:
          • Andrew A. Muskovitz
      • Detroit、Michigan、美国、48202
        • 招聘中
        • Henry Ford Hospital
        • 接触:
        • 首席研究员:
          • Haythem Y. Ali
      • Detroit、Michigan、美国、48201
        • 主动,不招人
        • Wayne State University/Karmanos Cancer Institute
      • Detroit、Michigan、美国、48236
        • 招聘中
        • Henry Ford Health Saint John Hospital
        • 首席研究员:
          • Tareq Al baghdadi
        • 接触:
      • East China Township、Michigan、美国、48054
        • 招聘中
        • Henry Ford River District Hospital
        • 首席研究员:
          • Tareq Al baghdadi
        • 接触:
      • Farmington Hills、Michigan、美国、48334
        • 主动,不招人
        • Weisberg Cancer Treatment Center
      • Farmington Hills、Michigan、美国、48336
        • 招聘中
        • Corewell Health Farmington Hills Hospital
        • 接触:
          • Site Public Contact
          • 电话号码:248-551-7695
        • 首席研究员:
          • Andrew A. Muskovitz
      • Flint、Michigan、美国、48503
        • 招聘中
        • Genesys Hurley Cancer Institute
        • 接触:
        • 首席研究员:
          • Tareq Al baghdadi
      • Flint、Michigan、美国、48503
        • 招聘中
        • Hurley Medical Center
        • 接触:
        • 首席研究员:
          • Tareq Al baghdadi
      • Flint、Michigan、美国、48503
        • 暂停
        • Genesee Hematology Oncology PC
      • Flint、Michigan、美国、48503
        • 招聘中
        • Cancer Hematology Centers - Flint
        • 接触:
        • 首席研究员:
          • Tareq Al baghdadi
      • Grand Rapids、Michigan、美国、49503
        • 招聘中
        • Trinity Health Grand Rapids Hospital
        • 接触:
        • 首席研究员:
          • Tareq Al baghdadi
      • Grand Rapids、Michigan、美国、49503
        • 招聘中
        • Corewell Health Grand Rapids Hospitals - Butterworth Hospital
        • 接触:
        • 首席研究员:
          • Kathleen Y. Butler
      • Grosse Pointe Woods、Michigan、美国、48236
        • 招聘中
        • Henry Ford Saint John Hospital - Breast
        • 接触:
        • 首席研究员:
          • Tareq Al baghdadi
      • Grosse Pointe Woods、Michigan、美国、48236
        • 招聘中
        • Henry Ford Saint John Hospital - Academic
        • 首席研究员:
          • Tareq Al baghdadi
        • 接触:
      • Grosse Pointe Woods、Michigan、美国、48236
        • 招聘中
        • Henry Ford Saint John Hospital - Van Elslander
        • 首席研究员:
          • Tareq Al baghdadi
        • 接触:
      • Jackson、Michigan、美国、49201
        • 招聘中
        • Allegiance Health
        • 接触:
        • 首席研究员:
          • Haythem Y. Ali
      • Kalamazoo、Michigan、美国、49007
        • 招聘中
        • Bronson Methodist Hospital
        • 接触:
        • 首席研究员:
          • Kathleen Y. Butler
      • Kalamazoo、Michigan、美国、49007
        • 招聘中
        • West Michigan Cancer Center
        • 接触:
        • 首席研究员:
          • Kathleen Y. Butler
      • Lansing、Michigan、美国、48910
        • 主动,不招人
        • Karmanos Cancer Institute at McLaren Greater Lansing
      • Livonia、Michigan、美国、48154
        • 招聘中
        • Trinity Health Saint Mary Mercy Livonia Hospital
        • 接触:
        • 首席研究员:
          • Tareq Al baghdadi
      • Macomb、Michigan、美国、48044
        • 招聘中
        • Henry Ford Warren Hospital - Breast Macomb
        • 首席研究员:
          • Tareq Al baghdadi
        • 接触:
      • Macomb、Michigan、美国、48044
        • 招聘中
        • Henry Ford Saint John Hospital - Macomb Medical
        • 首席研究员:
          • Tareq Al baghdadi
        • 接触:
      • Muskegon、Michigan、美国、49444
        • 招聘中
        • Trinity Health Muskegon Hospital
        • 接触:
        • 首席研究员:
          • Tareq Al baghdadi
      • Niles、Michigan、美国、49120
        • 招聘中
        • Corewell Health Lakeland Hospitals - Niles Hospital
        • 接触:
          • Site Public Contact
          • 电话号码:616-391-1230
        • 首席研究员:
          • Kathleen Y. Butler
      • Norton Shores、Michigan、美国、49444
        • 暂停
        • Cancer and Hematology Centers of Western Michigan - Norton Shores
      • Novi、Michigan、美国、48377
        • 招聘中
        • Henry Ford Medical Center-Columbus
        • 接触:
        • 首席研究员:
          • Haythem Y. Ali
      • Pontiac、Michigan、美国、48341
        • 招聘中
        • Trinity Health Saint Joseph Mercy Oakland Hospital
        • 接触:
        • 首席研究员:
          • Tareq Al baghdadi
      • Reed City、Michigan、美国、49677
        • 招聘中
        • Corewell Health Reed City Hospital
        • 接触:
        • 首席研究员:
          • Kathleen Y. Butler
      • Royal Oak、Michigan、美国、48073
        • 招聘中
        • Corewell Health William Beaumont University Hospital
        • 接触:
          • Site Public Contact
          • 电话号码:248-551-7695
        • 首席研究员:
          • Andrew A. Muskovitz
      • Saint Joseph、Michigan、美国、49085
        • 招聘中
        • Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
        • 接触:
        • 首席研究员:
          • Kathleen Y. Butler
      • Saint Joseph、Michigan、美国、49085
        • 招聘中
        • Corewell Health Lakeland Hospitals - Saint Joseph Hospital
        • 接触:
        • 首席研究员:
          • Kathleen Y. Butler
      • Traverse City、Michigan、美国、49684
        • 招聘中
        • Munson Medical Center
        • 接触:
        • 首席研究员:
          • Kathleen Y. Butler
      • Troy、Michigan、美国、48085
        • 招聘中
        • Corewell Health Beaumont Troy Hospital
        • 接触:
          • Site Public Contact
          • 电话号码:248-551-7695
        • 首席研究员:
          • Andrew A. Muskovitz
      • Warren、Michigan、美国、48093
        • 招聘中
        • Henry Ford Madison Heights Hospital - Breast
        • 首席研究员:
          • Tareq Al baghdadi
        • 接触:
      • Warren、Michigan、美国、48093
        • 招聘中
        • Henry Ford Health Warren Hospital
        • 首席研究员:
          • Tareq Al baghdadi
        • 接触:
      • Warren、Michigan、美国、48093
        • 招聘中
        • Henry Ford Warren Hospital - GLCMS
        • 首席研究员:
          • Tareq Al baghdadi
        • 接触:
      • West Bloomfield、Michigan、美国、48322
        • 招聘中
        • Henry Ford West Bloomfield Hospital
        • 接触:
        • 首席研究员:
          • Haythem Y. Ali
      • Wyandotte、Michigan、美国、48192
        • 招聘中
        • Henry Ford Wyandotte Hospital
        • 首席研究员:
          • Haythem Y. Ali
        • 接触:
      • Wyoming、Michigan、美国、49519
        • 招聘中
        • University of Michigan Health - West
        • 接触:
        • 首席研究员:
          • Kathleen Y. Butler
      • Ypsilanti、Michigan、美国、48106
      • Ypsilanti、Michigan、美国、48197
        • 招聘中
        • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
        • 接触:
        • 首席研究员:
          • Tareq Al baghdadi
    • Minnesota
      • Burnsville、Minnesota、美国、55337
        • 招聘中
        • Minnesota Oncology - Burnsville
        • 接触:
        • 首席研究员:
          • David M. King
      • Duluth、Minnesota、美国、55805
        • 主动,不招人
        • Saint Luke's Hospital of Duluth
      • Edina、Minnesota、美国、55435
        • 招聘中
        • Fairview Southdale Hospital
        • 接触:
        • 首席研究员:
          • David M. King
      • Edina、Minnesota、美国、55435
        • 招聘中
        • Minnesota Oncology - Edina
        • 接触:
        • 首席研究员:
          • David M. King
      • Minneapolis、Minnesota、美国、55407
        • 招聘中
        • Abbott-Northwestern Hospital
        • 接触:
        • 首席研究员:
          • David M. King
      • Minneapolis、Minnesota、美国、55415
        • 招聘中
        • Hennepin County Medical Center
        • 接触:
        • 首席研究员:
          • David M. King
      • Rochester、Minnesota、美国、55905
        • 招聘中
        • Mayo Clinic in Rochester
        • 首席研究员:
          • Jacob Orme
        • 接触:
          • Site Public Contact
          • 电话号码:855-776-0015
      • Saint Louis Park、Minnesota、美国、55416
        • 招聘中
        • Park Nicollet Clinic - Saint Louis Park
        • 接触:
        • 首席研究员:
          • David M. King
      • Saint Paul、Minnesota、美国、55101
        • 招聘中
        • Regions Hospital
        • 接触:
        • 首席研究员:
          • David M. King
      • Saint Paul、Minnesota、美国、55102
        • 招聘中
        • United Hospital
        • 接触:
        • 首席研究员:
          • David M. King
      • Shakopee、Minnesota、美国、55379
        • 招聘中
        • Saint Francis Regional Medical Center
        • 接触:
        • 首席研究员:
          • David M. King
    • Missouri
      • Cape Girardeau、Missouri、美国、63703
        • 招聘中
        • Saint Francis Medical Center
        • 首席研究员:
          • Bryan A. Faller
        • 接触:
          • Site Public Contact
          • 电话号码:573-334-2230
          • 邮箱:sfmc@sfmc.net
      • Joplin、Missouri、美国、64804
        • 招聘中
        • Mercy Hospital Joplin
        • 首席研究员:
          • Jay W. Carlson
        • 接触:
      • Springfield、Missouri、美国、65804
        • 招聘中
        • Mercy Hospital Springfield
        • 首席研究员:
          • Jay W. Carlson
        • 接触:
          • Site Public Contact
          • 电话号码:417-269-4520
      • Springfield、Missouri、美国、65807
        • 招聘中
        • CoxHealth South Hospital
        • 首席研究员:
          • Jay W. Carlson
        • 接触:
          • Site Public Contact
          • 电话号码:417-269-4520
      • St Louis、Missouri、美国、63128
        • 招聘中
        • Mercy Hospital South
        • 首席研究员:
          • Jay W. Carlson
        • 接触:
    • Montana
      • Anaconda、Montana、美国、59711
        • 招聘中
        • Community Hospital of Anaconda
        • 首席研究员:
          • John M. Schallenkamp
        • 接触:
      • Billings、Montana、美国、59101
        • 招聘中
        • Billings Clinic Cancer Center
        • 首席研究员:
          • John M. Schallenkamp
        • 接触:
      • Billings、Montana、美国、59102
        • 招聘中
        • Saint Vincent Frontier Cancer Center
        • 接触:
          • Site Public Contact
          • 电话号码:800-648-6274
        • 首席研究员:
          • Patrick W. Cobb
      • Great Falls、Montana、美国、59405
        • 招聘中
        • Benefis Sletten Cancer Institute
        • 首席研究员:
          • John M. Schallenkamp
        • 接触:
      • Kalispell、Montana、美国、59901
        • 招聘中
        • Logan Health Medical Center
        • 首席研究员:
          • John M. Schallenkamp
        • 接触:
      • Missoula、Montana、美国、59804
        • 招聘中
        • Community Medical Center
        • 首席研究员:
          • John M. Schallenkamp
        • 接触:
    • New Hampshire
      • Lebanon、New Hampshire、美国、03756
        • 招聘中
        • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
        • 接触:
        • 首席研究员:
          • Kathryn C. Hourdequin
    • New York
      • Buffalo、New York、美国、14263
        • 主动,不招人
        • Roswell Park Cancer Institute
      • New York、New York、美国、10029
        • 主动,不招人
        • Mount Sinai Hospital
      • Stony Brook、New York、美国、11794
        • 主动,不招人
        • Stony Brook University Medical Center
    • North Carolina
      • Cary、North Carolina、美国、27518
        • 暂停
        • Duke Cancer Center Cary
      • Charlotte、North Carolina、美国、28203
        • 招聘中
        • Carolinas Medical Center/Levine Cancer Institute
        • 首席研究员:
          • Earle F. Burgess
        • 接触:
          • Site Public Contact
          • 电话号码:800-804-9376
      • Charlotte、North Carolina、美国、28210
        • 招聘中
        • Atrium Health Pineville/LCI-Pineville
        • 首席研究员:
          • Earle F. Burgess
        • 接触:
          • Site Public Contact
          • 电话号码:980-442-2000
      • Charlotte、North Carolina、美国、28211
        • 招聘中
        • Levine Cancer Institute-SouthPark
        • 首席研究员:
          • Earle F. Burgess
        • 接触:
          • Site Public Contact
          • 电话号码:980-442-2000
      • Charlotte、North Carolina、美国、28262
        • 招聘中
        • Atrium Health University City/LCI-University
        • 首席研究员:
          • Earle F. Burgess
        • 接触:
          • Site Public Contact
          • 电话号码:800-804-9376
      • Charlotte、North Carolina、美国、28277
        • 招聘中
        • Levine Cancer Institute-Ballantyne
        • 首席研究员:
          • Earle F. Burgess
        • 接触:
          • Site Public Contact
          • 电话号码:800-804-9376
      • Clinton、North Carolina、美国、28328
        • 招聘中
        • Southeastern Medical Oncology Center-Clinton
        • 接触:
        • 首席研究员:
          • Samer S. Kasbari
      • Concord、North Carolina、美国、28025
        • 招聘中
        • Atrium Health Cabarrus/LCI-Concord
        • 首席研究员:
          • Earle F. Burgess
        • 接触:
          • Site Public Contact
          • 电话号码:800-804-9376
      • Durham、North Carolina、美国、27710
        • 招聘中
        • Duke University Medical Center
        • 接触:
          • Site Public Contact
          • 电话号码:888-275-3853
        • 首席研究员:
          • Tucker Coston
      • Gastonia、North Carolina、美国、28054
        • 招聘中
        • Levine Cancer Institute-Gaston
        • 首席研究员:
          • Earle F. Burgess
        • 接触:
          • Site Public Contact
          • 电话号码:800-804-9376
      • Goldsboro、North Carolina、美国、27534
        • 招聘中
        • Southeastern Medical Oncology Center-Goldsboro
        • 接触:
        • 首席研究员:
          • Samer S. Kasbari
      • Jacksonville、North Carolina、美国、28546
        • 招聘中
        • Southeastern Medical Oncology Center-Jacksonville
        • 首席研究员:
          • Samer S. Kasbari
        • 接触:
      • Pinehurst、North Carolina、美国、28374
        • 招聘中
        • FirstHealth of the Carolinas-Moore Regional Hospital
        • 接触:
        • 首席研究员:
          • Charles S. Kuzma
      • Raleigh、North Carolina、美国、27609
        • 招聘中
        • Duke Cancer Center Raleigh
        • 接触:
        • 首席研究员:
          • Tucker Coston
      • Shelby、North Carolina、美国、28150
        • 招聘中
        • Atrium Health Cleveland/LCI-Cleveland
        • 首席研究员:
          • Earle F. Burgess
        • 接触:
          • Site Public Contact
          • 电话号码:800-804-9376
    • Ohio
      • Columbus、Ohio、美国、43210
        • 招聘中
        • Ohio State University Comprehensive Cancer Center
        • 接触:
        • 首席研究员:
          • Bhavana Konda
      • Toledo、Ohio、美国、43623
        • 暂停
        • Toledo Clinic Cancer Centers-Toledo
    • Oklahoma
      • Lawton、Oklahoma、美国、73505
        • 招聘中
        • Cancer Centers of Southwest Oklahoma Research
        • 接触:
          • Site Public Contact
          • 电话号码:877-231-4440
        • 首席研究员:
          • Sagila George
      • Oklahoma City、Oklahoma、美国、73104
        • 招聘中
        • University of Oklahoma Health Sciences Center
        • 接触:
        • 首席研究员:
          • Sagila George
      • Oklahoma City、Oklahoma、美国、73120
        • 招聘中
        • Mercy Hospital Oklahoma City
        • 首席研究员:
          • Jay W. Carlson
        • 接触:
          • Site Public Contact
          • 电话号码:405-752-3402
    • Oregon
      • Bend、Oregon、美国、97701
        • 招聘中
        • Saint Charles Health System
        • 接触:
        • 首席研究员:
          • Charles W. Drescher
      • Clackamas、Oregon、美国、97015
        • 暂停
        • Providence Cancer Institute Clackamas Clinic
      • Newberg、Oregon、美国、97132
        • 招聘中
        • Providence Newberg Medical Center
        • 接触:
        • 首席研究员:
          • Charles W. Drescher
      • Oregon City、Oregon、美国、97045
        • 招聘中
        • Providence Willamette Falls Medical Center
        • 接触:
        • 首席研究员:
          • Charles W. Drescher
      • Portland、Oregon、美国、97213
        • 招聘中
        • Providence Portland Medical Center
        • 接触:
        • 首席研究员:
          • Charles W. Drescher
      • Portland、Oregon、美国、97225
        • 招聘中
        • Providence Saint Vincent Medical Center
        • 接触:
        • 首席研究员:
          • Charles W. Drescher
    • Pennsylvania
      • Chambersburg、Pennsylvania、美国、17201
        • 招聘中
        • WellSpan Medical Oncology and Hematology
        • 接触:
          • Site Public Contact
          • 电话号码:717-217-6020
        • 首席研究员:
          • Marianne Spengler
      • Ephrata、Pennsylvania、美国、17522
        • 招聘中
        • Ephrata Cancer Center
        • 接触:
          • Site Public Contact
          • 电话号码:717-721-4840
        • 首席研究员:
          • Marianne Spengler
      • Gettysburg、Pennsylvania、美国、17325
        • 招聘中
        • Adams Cancer Center
        • 接触:
          • Site Public Contact
          • 电话号码:877-441-7957
        • 首席研究员:
          • Marianne Spengler
      • Hanover、Pennsylvania、美国、17331
        • 招聘中
        • WellSpan Medical Oncology and Hematology
        • 接触:
          • Site Public Contact
          • 电话号码:717-632-1559
        • 首席研究员:
          • Marianne Spengler
      • Lebanon、Pennsylvania、美国、17042
        • 招聘中
        • Sechler Family Cancer Center
        • 接触:
        • 首席研究员:
          • Marianne Spengler
      • York、Pennsylvania、美国、17403
        • 招聘中
        • WellSpan Health-York Cancer Center
        • 接触:
          • Site Public Contact
          • 电话号码:877-441-7957
        • 首席研究员:
          • Marianne Spengler
      • York、Pennsylvania、美国、17403
        • 暂停
        • Cancer Care Associates of York
    • Rhode Island
      • Westerly、Rhode Island、美国、02891
        • 招聘中
        • Smilow Cancer Hospital Care Center - Westerly
        • 接触:
        • 首席研究员:
          • Matthew Austin
    • South Carolina
      • Charleston、South Carolina、美国、29425
        • 暂停
        • Medical University of South Carolina
      • Rock Hill、South Carolina、美国、29732
        • 招聘中
        • Levine Cancer Institute-Rock Hill
        • 首席研究员:
          • Earle F. Burgess
        • 接触:
          • Site Public Contact
          • 电话号码:800-804-9376
    • South Dakota
      • Rapid City、South Dakota、美国、57701
        • 招聘中
        • Rapid City Regional Hospital
        • 首席研究员:
          • Abdel-Ghani Azzouqa
        • 接触:
    • Tennessee
      • Nashville、Tennessee、美国、37232
        • 招聘中
        • Vanderbilt University/Ingram Cancer Center
        • 接触:
          • Site Public Contact
          • 电话号码:800-811-8480
        • 首席研究员:
          • Robert A. Ramirez
    • Texas
      • Dallas、Texas、美国、75390
        • 招聘中
        • UT Southwestern/Simmons Cancer Center-Dallas
        • 接触:
        • 首席研究员:
          • Namrata I. Peswani
      • Dallas、Texas、美国、75235
        • 招聘中
        • Parkland Memorial Hospital
        • 接触:
        • 首席研究员:
          • Namrata I. Peswani
      • Dallas、Texas、美国、75237
        • 招聘中
        • UT Southwestern Simmons Cancer Center - RedBird
        • 首席研究员:
          • Namrata I. Peswani
        • 接触:
      • Fort Worth、Texas、美国、76104
        • 招聘中
        • UT Southwestern/Simmons Cancer Center-Fort Worth
        • 接触:
        • 首席研究员:
          • Namrata I. Peswani
      • Houston、Texas、美国、77030
        • 招聘中
        • Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
        • 首席研究员:
          • Tannaz Armaghany
        • 接触:
          • Site Public Contact
          • 电话号码:713-798-1354
          • 邮箱:burton@bcm.edu
      • Houston、Texas、美国、77030
        • 招聘中
        • Ben Taub General Hospital
        • 首席研究员:
          • Tannaz Armaghany
        • 接触:
          • Site Public Contact
          • 电话号码:713-873-2000
      • Richardson、Texas、美国、75080
        • 招聘中
        • UT Southwestern Clinical Center at Richardson/Plano
        • 接触:
        • 首席研究员:
          • Namrata I. Peswani
    • Utah
      • Salt Lake City、Utah、美国、84112
        • 招聘中
        • Huntsman Cancer Institute/University of Utah
        • 接触:
        • 首席研究员:
          • Heloisa P. Soares
    • Vermont
      • Saint Johnsbury、Vermont、美国、05819
        • 招聘中
        • Dartmouth Cancer Center - North
        • 接触:
        • 首席研究员:
          • Kathryn C. Hourdequin
    • Washington
      • Seattle、Washington、美国、98195
        • 招聘中
        • University of Washington Medical Center - Montlake
        • 接触:
          • Site Public Contact
          • 电话号码:800-804-8824
        • 首席研究员:
          • David B. Zhen
      • Seattle、Washington、美国、98109
        • 招聘中
        • Fred Hutchinson Cancer Center
        • 接触:
          • Site Public Contact
          • 电话号码:800-804-8824
        • 首席研究员:
          • David B. Zhen
    • West Virginia
      • Bridgeport、West Virginia、美国、26330
        • 招聘中
        • United Hospital Center
        • 接触:
        • 首席研究员:
          • Nour Daboul
      • Morgantown、West Virginia、美国、26506
        • 招聘中
        • West Virginia University Healthcare
        • 接触:
        • 首席研究员:
          • Nour Daboul
    • Wisconsin
      • Eau Claire、Wisconsin、美国、54701
      • La Crosse、Wisconsin、美国、54601
        • 招聘中
        • Gundersen Lutheran Medical Center
        • 接触:
        • 首席研究员:
          • David E. Marinier
      • Marshfield、Wisconsin、美国、54449
      • Milwaukee、Wisconsin、美国、53226
        • 招聘中
        • Medical College of Wisconsin
        • 接触:
          • Site Public Contact
          • 电话号码:414-805-3666
        • 首席研究员:
          • Alexandria T. Phan
      • Minocqua、Wisconsin、美国、54548
      • Rice Lake、Wisconsin、美国、54868
      • Stevens Point、Wisconsin、美国、54482
      • Weston、Wisconsin、美国、54476

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Participants must have histologically-confirmed (local site pathological confirmation sufficient) extrapulmonary poorly differentiated, neuroendocrine carcinoma (NEC)

  • Participants must have disease that is unresectable or metastatic and not eligible for definitive therapy as deemed per the treating investigator

  • Participants must have radiologically evaluable disease, measurable or non-measurable, per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria. All measurable and nonmeasurable lesions must be assessed by CT scan with IV contrast of the chest/abdomen/and pelvis (or CT chest without contrast and MRI abdomen/pelvis with gadolinium contrast, if contraindication to CT iodinated contrast) within 28 days prior to registration. While may be used for routine clinical evaluation, PET scans and bone scans alone are not acceptable for disease assessment while participating in this study. All known sites of disease must be assessed and documented on the Baseline Tumor Assessment Form

  • Participants must have brain MRI (or CT head with contrast if there is contraindication to MRI brain) if clinically indicated within 28 days prior to registration. Note: Brain imaging is not required in participants without known and/or clinical concern for brain metastases. Participants with asymptomatic central nervous system (CNS) metastases are eligible if one or more of the following apply:

    • Participants who have received treatment for brain metastases must have:

      • No evidence of radiological progression (by MRI brain or CT head with contrast if there is contraindication to MRI brain) within 28 days prior to registration
      • Discontinued all corticosteroids at least 14 days prior to registration
    • Participants with treatment-naive brain lesions must have:

      • No lesion measuring > 2.0 cm in size in any axis
      • MRI brain or CT head with contrast (if there is contraindication to MRI brain) demonstrating no evidence for mass effect, edema, or other impending neurological compromise within 28 days prior to registration
      • No evidence of radiological progression (by MRI brain or CT head with contrast if there is contraindication to MRI brain) within 28 days prior to registration
      • No need for > 2 mg of dexamethasone (or equivalent of > 10 mg prednisone) per day at time of registration
  • Participants must not have symptomatic central nervous system (CNS) metastases

  • Participants must not have known or suspected leptomeningeal disease

  • Participants with prior history of non-metastatic (localized/locally advanced disease) extrapulmonary poorly differentiated NEC may have had prior platinum-based therapy +/- radiation +/- surgery provided that all therapy was completed >= 6 months prior to registration

  • Participants must discontinue denosumab prior to study registration and plan to replace with a bisphosphonate while on the study

  • Participants must not have had prior treatment for advanced or metastatic NEC EXCEPT one cycle of platinum (carboplatin/cisplatin) + etoposide is allowed prior to registration. Other chemotherapy regimens are not allowed. For participants with prostate or urothelial NEC, prior chemotherapy for the non-NEC component (e.g. adenocarcinoma or urothelial) is allowed as long as such therapy was completed >= 24 weeks prior to registration and participants have recovered from all prior toxicities to =< grade 1.

  • Participants must not have had prior treatment with an anti-PD-1, anti-PD-L1, antiPD-L2, CD137 agonists, anti-CTLA-4 agent, or any other immune checkpoint inhibitors for any neuroendocrine neoplasm. Immune checkpoint inhibitors given for other cancer indications are allowed provided last therapy was given at least 12 months prior to study registration

  • Participants must not have received treatment with systemic immunostimulatory agents including, but not limited to, interferon and interleukin2 [IL-2] within 4 weeks or 5 half-lives of the drug (whichever is longer) prior to registration

  • Participants must not have had history of known severe allergy, anaphylactic, or other hypersensitivity reactions to chimeric or humanized antibodies, including to Chinese hamster ovary cell products or to any component of the atezolizumab formulation, cisplatin, carboplatin, or etoposide

  • Participants must not be on active systemic therapy for another cancer with the exception of hormonal therapy including androgen deprivation therapy (e.g., gonadotropin-releasing hormone [GnRH] agonists or antagonists), which can be continued while participants are receiving protocol therapy. Use of enzalutamide or apalutamide is permitted after completion of chemotherapy and must be held during chemotherapy for participants receiving prior to enrollment. Use of darolutamide is permitted during chemotherapy. Glucocorticoid-containing regimens, including abiraterone, are not permitted.

  • Participants must be >= 18 years of age

  • Participants must have a Zubrod performance status of =< 2 within 28 days prior to registration

  • Participants must have a complete medical history and physical exam within 28 days prior to registration

  • Absolute neutrophil count (ANC) >= 1.5 x 10^9 /L (obtained within 14 days prior to registration. For participants who received a cycle of chemotherapy prior to registration, at least 21 days must have elapsed between day 1 of platinum + etoposide and performance of these tests)

  • Hemoglobin >= 9.0 g/dl (obtained within 14 days prior to registration. For participants who received a cycle of chemotherapy prior to registration, at least 21 days must have elapsed between day 1 of platinum + etoposide and performance of these tests)

  • Platelet count >= 100 x 10^9/L (obtained within 14 days prior to registration. For participants who received a cycle of chemotherapy prior to registration, at least 21 days must have elapsed between day 1 of platinum + etoposide and performance of these tests)

  • Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< 2.5 x institutional upper limit of normal (ULN) (obtained within 14 days prior to registration. For participants who received a cycle of chemotherapy prior to registration, at least 21 days must have elapsed between day 1 of platinum + etoposide and performance of these tests)

  • Serum total bilirubin =< 1.5 x ULN (obtained within 14 days prior to registration. For participants who received a cycle of chemotherapy prior to registration, at least 21 days must have elapsed between day 1 of platinum + etoposide and performance of these tests)

  • Adequate renal function as defined by any 1 of the following: 1) Measured creatinine clearance (CL) > 50 mL/min OR 2) Calculated creatinine CL > 50 mL/min by the Cockcroft-Gault formula OR by 24-hour urine collection for determination of creatinine clearance (obtained within 14 days prior to registration. For participants who received a cycle of chemotherapy prior to registration, at least 21 days must have elapsed between day 1 of platinum + etoposide and performance of these tests)

  • Participants must not have uncontrolled or symptomatic hypercalcemia (> 1.5 mmol/L ionized calcium or calcium > 12 mg/dL or corrected serum calcium > ULN) within 14 days prior to registration. Participants who have asymptomatic hypercalcemia are eligible provided that medical therapy to treat the hypercalcemia is planned

  • Participants must not have a diagnosis of immunodeficiency nor be receiving systemic steroid therapy (equivalent of > 20 mg of hydrocortisone per day) or any other form of immunosuppressive therapy within 14 days prior to registration

  • Participants must not have active or history of autoimmune disease or immune deficiency, including, but not limited to myasthenia gravis, myositis, autoimmune hepatitis, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, antiphospholipid antibody syndrome, Wegener granulomatosis, Sjogren syndrome, Guillain-Barre syndrome, or multiple sclerosis with the following exceptions:

    • Patients with a history of autoimmune-related hypothyroidism who are on thyroid-replacement hormone are eligible for the study

    • Patients with controlled type 1 diabetes mellitus who are on an insulin regimen are eligible for the study

    • Patients with eczema, psoriasis, lichen simplex chronicus, or vitiligo with dermatologic manifestations only (e.g., patients with psoriatic arthritis are excluded) are eligible for the study provided all of following conditions are met:

      • Rash must cover < 10% of body surface area
      • Disease is well controlled at baseline and requires only low-potency topical corticosteroids
      • No occurrence of acute exacerbations of the underlying condition requiring psoralen plus ultraviolet A radiation, methotrexate, retinoids, biologic agents, oral calcineurin inhibitors, or high-potency or oral corticosteroids within the previous 12 months
  • Participants must not have history of idiopathic pulmonary fibrosis, organizing pneumonia (e.g., bronchiolitis obliterans), drug-induced pneumonitis, idiopathic pneumonitis, or evidence of active pneumonitis on screening chest CT scan. NOTE: History of radiation pneumonitis in the radiation field (fibrosis) is permitted

  • Participants must not have significant cardiovascular disease, such as New York Heart Association class II or greater cardiac disease, myocardial infarction within 3 months prior to registration, unstable arrythmias, or unstable angina

  • Participants must not have had a major surgical procedure other than for diagnosis within 28 days prior to registration. Participant must not plan to receive a major surgical procedure during the course of protocol treatment. NOTE: Patient port placement is not considered a major surgery

  • Participants must not have severe infections (i.e., Common Terminology Criteria for Adverse Events [CTCAE] grade >= 2) at time of registration, including but not limited to hospitalization for complications for infection, bacteremia, or severe pneumonia

  • Participants must not have known active tuberculosis

  • Participants with evidence of chronic hepatitis B virus (HBV) infection must have undetectable HBV viral load, with testing performed as clinically indicated

  • Participants with a history of hepatitis C virus (HCV) infection must have been treated and cured. Participants with active HCV infection who are currently on treatment must have an undetectable HCV viral load, with testing performed as clinically indicated

  • Participants with known human immunodeficiency virus (HIV)-infection must be on effective anti-retroviral therapy at time of registration and have undetectable HIV viral load within 6 months of registration

  • Participants must not have prior allogeneic bone marrow transplantation or solid organ transplant

  • Participants must not have received administration of a live, attenuated vaccine (e.g., FluMist [registered trademark]) within 28 days prior to initiation of study treatment, during treatment with atezolizumab, and not plan to receive for 5 months after the last dose of atezolizumab

  • Participants must not be pregnant due to the possibility of harm to the fetus. Individuals who are of reproductive potential must have agreed to use an effective contraceptive method (with details provided as a part of the consent process) during the treatment period and for 5 months after the final dose of atezolizumab. A person who has had menses at any time in the preceding 12 consecutive months or who has semen likely to contain sperm is considered to be of "reproductive potential." In addition to routine contraceptive methods, "effective contraception" also includes refraining from sexual activity that might result in pregnancy and surgery intended to prevent pregnancy (or with a side effect of pregnancy prevention) including hysterectomy, bilateral oophorectomy, bilateral tubal ligation/occlusion, and vasectomy with testing showing no sperm in the semen

  • Participants must be offered the opportunity to participate in specimen banking. With participant consent, specimens must be collected and submitted via the Southwest Oncology Group (SWOG) Specimen Tracking System

  • Participants must be informed of the investigational nature of this study and must sign and give informed consent in accordance with institutional and federal guidelines

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Arm I (atezolizumab, platinum drug, etoposide)

During induction phase, patients receive atezolizumab IV over 30-60 minutes on day 1 of each cycle, carboplatin IV over 30 minutes or cisplatin IV over 60 minutes on day 1 of each cycle, and etoposide IV on days 1-3 of each cycle. Treatment repeats every 21 days for 4 cycles in the absence of disease progression or unacceptable toxicity. During maintenance phase, patients receive atezolizumab IV over 30-60 minutes on day 1 of each cycle. Treatment repeats every 21 days for up to 17 cycles in the absence of disease progression or unacceptable toxicity. Patients also undergo CT scan and/or MRI throughout the trial and blood sample collection on study.

Given IV

其他名称:
  • 芽生威
  • 卡宝
  • 卡铂六醇
  • 卡铂
  • 卡布辛
  • 卡波索尔
  • 卡博泰克
  • CBDCA
  • 迪普拉塔
  • 埃卡尔
  • JM-8
  • 内洛林
  • 新铂金
  • 副铂
  • 副铂 AQ
  • 对铂
  • 铂金瓦斯
  • 核糖体
  • JM8

Given IV

其他名称:
  • CDDP
  • 顺式二氨合二氯铂
  • 顺铂
  • 新铂
  • 铂醇
  • 阿比铂
  • Blastolem
  • 布铂
  • 顺式二氨二氯铂
  • 顺式二氨二氯铂 (II)
  • 顺式二氯胺铂 (II)
  • 顺铂二氯化胺
  • 顺铂II
  • 顺铂II二胺二氯化物
  • 胞铂
  • 胞磷胆素
  • 扁豆属
  • 民进党
  • 莱德铂
  • 金属铂
  • 佩龙氯化物
  • 佩龙盐
  • 普拉西斯
  • 塑化剂
  • 铂金
  • 铂菌素
  • Platiblastin-S
  • 铂金-AQ
  • Platinol-AQ VHA Plus
  • 铂氧生
  • 铂
  • 二氯化铂
  • 普拉蒂兰
  • 普拉汀
  • 柏拉图素

Undergo blood sample collection

其他名称:
  • 生物样本采集
  • 收集的生物样本
  • 标本采集
  • 样本收集

Undergo MRI

其他名称:
  • 核磁共振
  • 磁共振
  • 磁共振成像扫描
  • 医学影像、磁共振/核磁共振
  • 先生
  • 磁共振成像
  • 核磁共振成像扫描
  • 核磁共振成像
  • 磁共振成像 (MRI)
  • 磁共振成像(程序)
  • 结构核磁共振

Given IV

其他名称:
  • 去甲基鬼臼毒素乙苷
  • EPEG
  • 拉斯特
  • 拓扑萨
  • 韦贝斯
  • 副总裁 16
  • 副总裁 16-213
  • VP-16
  • VP-16-213
  • VP16
  • 副总裁 16213
  • VP-16213
  • VP16213

Undergo CT scan

其他名称:
  • CT
  • 猫
  • 电脑扫描
  • 计算机轴向断层扫描
  • 计算机断层扫描
  • CT扫描
  • 断层扫描
  • 计算机轴向断层扫描(程序)
  • 计算机断层扫描 (CT) 扫描
  • 诊断猫扫描
  • 诊断猫扫描服务类型

Given IV

其他名称:
  • 技术中心
  • MPDL3280A
  • RO5541267
  • RG7446
  • MPDL 3280A
  • MPDL 328OA
  • MPDL-3280A
  • MPDL328OA
  • RG-7446
  • RG 7446
  • RO 5541267
  • RO-5541267
实验性的:Arm II (atezolizumab, platinum drug, etoposide, observation)

During induction phase, patients receive atezolizumab IV over 30-60 minutes on day 1 of each cycle, carboplatin IV over 30 minutes or cisplatin IV over 60 minutes on day 1 of each cycle, and etoposide IV on days 1-3 of each cycle. Treatment repeats every 21 days for 4 cycles in the absence of disease progression or unacceptable toxicity. Patients then undergo observation for 1 year. Patients also undergo CT scan and/or MRI throughout the trial and blood sample collection on study. (CLOSED TO ACCRUAL 7/9/26)

Given IV

其他名称:
  • 芽生威
  • 卡宝
  • 卡铂六醇
  • 卡铂
  • 卡布辛
  • 卡波索尔
  • 卡博泰克
  • CBDCA
  • 迪普拉塔
  • 埃卡尔
  • JM-8
  • 内洛林
  • 新铂金
  • 副铂
  • 副铂 AQ
  • 对铂
  • 铂金瓦斯
  • 核糖体
  • JM8

Given IV

其他名称:
  • CDDP
  • 顺式二氨合二氯铂
  • 顺铂
  • 新铂
  • 铂醇
  • 阿比铂
  • Blastolem
  • 布铂
  • 顺式二氨二氯铂
  • 顺式二氨二氯铂 (II)
  • 顺式二氯胺铂 (II)
  • 顺铂二氯化胺
  • 顺铂II
  • 顺铂II二胺二氯化物
  • 胞铂
  • 胞磷胆素
  • 扁豆属
  • 民进党
  • 莱德铂
  • 金属铂
  • 佩龙氯化物
  • 佩龙盐
  • 普拉西斯
  • 塑化剂
  • 铂金
  • 铂菌素
  • Platiblastin-S
  • 铂金-AQ
  • Platinol-AQ VHA Plus
  • 铂氧生
  • 铂
  • 二氯化铂
  • 普拉蒂兰
  • 普拉汀
  • 柏拉图素

Undergo blood sample collection

其他名称:
  • 生物样本采集
  • 收集的生物样本
  • 标本采集
  • 样本收集

Undergo MRI

其他名称:
  • 核磁共振
  • 磁共振
  • 磁共振成像扫描
  • 医学影像、磁共振/核磁共振
  • 先生
  • 磁共振成像
  • 核磁共振成像扫描
  • 核磁共振成像
  • 磁共振成像 (MRI)
  • 磁共振成像(程序)
  • 结构核磁共振

Given IV

其他名称:
  • 去甲基鬼臼毒素乙苷
  • EPEG
  • 拉斯特
  • 拓扑萨
  • 韦贝斯
  • 副总裁 16
  • 副总裁 16-213
  • VP-16
  • VP-16-213
  • VP16
  • 副总裁 16213
  • VP-16213
  • VP16213

Undergo CT scan

其他名称:
  • CT
  • 猫
  • 电脑扫描
  • 计算机轴向断层扫描
  • 计算机断层扫描
  • CT扫描
  • 断层扫描
  • 计算机轴向断层扫描(程序)
  • 计算机断层扫描 (CT) 扫描
  • 诊断猫扫描
  • 诊断猫扫描服务类型

Undergo observation

其他名称:
  • 观察
  • 主动监控
  • 延期治疗
  • 期待管理
  • 观察等待

Given IV

其他名称:
  • 技术中心
  • MPDL3280A
  • RO5541267
  • RG7446
  • MPDL 3280A
  • MPDL 328OA
  • MPDL-3280A
  • MPDL328OA
  • RG-7446
  • RG 7446
  • RO 5541267
  • RO-5541267
有源比较器:Arm III (platinum drug, etoposide, observation)

During induction phase, patients receive carboplatin IV over 30 minutes or cisplatin IV over 60 minutes on day 1 of each cycle and etoposide IV on days 1-3 of each cycle. Treatment repeats every 21 days for 4 cycles in the absence of disease progression or unacceptable toxicity. Patients then undergo observation for 1 year. Patients also undergo CT scan and/or MRI throughout the trial and blood sample collection on study.

Given IV

其他名称:
  • 芽生威
  • 卡宝
  • 卡铂六醇
  • 卡铂
  • 卡布辛
  • 卡波索尔
  • 卡博泰克
  • CBDCA
  • 迪普拉塔
  • 埃卡尔
  • JM-8
  • 内洛林
  • 新铂金
  • 副铂
  • 副铂 AQ
  • 对铂
  • 铂金瓦斯
  • 核糖体
  • JM8

Given IV

其他名称:
  • CDDP
  • 顺式二氨合二氯铂
  • 顺铂
  • 新铂
  • 铂醇
  • 阿比铂
  • Blastolem
  • 布铂
  • 顺式二氨二氯铂
  • 顺式二氨二氯铂 (II)
  • 顺式二氯胺铂 (II)
  • 顺铂二氯化胺
  • 顺铂II
  • 顺铂II二胺二氯化物
  • 胞铂
  • 胞磷胆素
  • 扁豆属
  • 民进党
  • 莱德铂
  • 金属铂
  • 佩龙氯化物
  • 佩龙盐
  • 普拉西斯
  • 塑化剂
  • 铂金
  • 铂菌素
  • Platiblastin-S
  • 铂金-AQ
  • Platinol-AQ VHA Plus
  • 铂氧生
  • 铂
  • 二氯化铂
  • 普拉蒂兰
  • 普拉汀
  • 柏拉图素

Undergo blood sample collection

其他名称:
  • 生物样本采集
  • 收集的生物样本
  • 标本采集
  • 样本收集

Undergo MRI

其他名称:
  • 核磁共振
  • 磁共振
  • 磁共振成像扫描
  • 医学影像、磁共振/核磁共振
  • 先生
  • 磁共振成像
  • 核磁共振成像扫描
  • 核磁共振成像
  • 磁共振成像 (MRI)
  • 磁共振成像(程序)
  • 结构核磁共振

Given IV

其他名称:
  • 去甲基鬼臼毒素乙苷
  • EPEG
  • 拉斯特
  • 拓扑萨
  • 韦贝斯
  • 副总裁 16
  • 副总裁 16-213
  • VP-16
  • VP-16-213
  • VP16
  • 副总裁 16213
  • VP-16213
  • VP16213

Undergo CT scan

其他名称:
  • CT
  • 猫
  • 电脑扫描
  • 计算机轴向断层扫描
  • 计算机断层扫描
  • CT扫描
  • 断层扫描
  • 计算机轴向断层扫描(程序)
  • 计算机断层扫描 (CT) 扫描
  • 诊断猫扫描
  • 诊断猫扫描服务类型

Undergo observation

其他名称:
  • 观察
  • 主动监控
  • 延期治疗
  • 期待管理
  • 观察等待

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Overall survival
大体时间:From date of registration or from date of start of observation/maintenance therapy to date of death due to any cause, assessed up to 5 years

Log-rank tests stratified by the randomization stratification factors will be used for null hypothesis (efficacy) tests. Cox regression models stratified by the randomization stratification factors will be used for alternative hypothesis (futility) tests.

From date of registration or from date of start of observation/maintenance therapy to date of death due to any cause, assessed up to 5 years

次要结果测量

结果测量
措施说明
大体时间
Progression-free survival
大体时间:From date of registration or start of observation/maintenance therapy to date of first documentation of progression or symptomatic deterioration, or death due to any cause, assessed up to 5 years

Will be estimated using the Kaplan-Meier method and compared using log-rank tests.

From date of registration or start of observation/maintenance therapy to date of first documentation of progression or symptomatic deterioration, or death due to any cause, assessed up to 5 years
Duration of response
大体时间:Time from date of initial response to date of progression or death, assessed up to 5 years

Will be estimated non-parametrically using cumulative incidence curves.

Time from date of initial response to date of progression or death, assessed up to 5 years
Objective response rate (confirmed complete response [CR] or partial response [PR])
大体时间:Up to 5 years from study enrollment

Will be tabulated and compared between arms using Fisher's exact test.

Up to 5 years from study enrollment
Clinical benefit rate (confirmed CR or PR of any amount of time or stable disease for 6 months or longer)
大体时间:Up to 5 years from study enrollment

Will be tabulated and compared between arms using Fisher's exact test.

Up to 5 years from study enrollment

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:David B Zhen、SWOG Cancer Research Network

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2022年6月28日

初级完成 (估计的)

2028年10月1日

研究完成 (估计的)

2028年10月1日

研究注册日期

首次提交

2021年9月25日

首先提交符合 QC 标准的

2021年9月25日

首次发布 (实际的)

2021年9月28日

研究记录更新

最后更新发布 (实际的)

2026年11月6日

上次提交的符合 QC 标准的更新

2026年11月5日

最后验证

2026年10月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

是的

研究美国 FDA 监管的设备产品

不

在美国制造并从美国出口的产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅